Assessing the clinical progress of Muvalaplin for lowering lipoprotein(a)
{{output}}
Introduction: Lipoprotein(a) [Lp(a)] is an LDL-like particle, which is synthesized and assembled in the liver, and whose plasma levels are strongly associated with, and considered to be causative of, atherosclerotic cardiovascula... ...